{"doc_id": "33264556", "type of study": "Therapy", "title": "", "abstract": "Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.\nWorld Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).\nWe randomly assigned inpatients with Covid-19 equally between one of the trial drug regimens that was locally available and open control (up to five options, four active and the local standard of care).\nThe intention-to-treat primary analyses examined in-hospital mortality in the four pairwise comparisons of each trial drug and its control (drug available but patient assigned to the same care without that drug).\nRate ratios for death were calculated with stratification according to age and status regarding mechanical ventilation at trial entry.\nAt 405 hospitals in 30 countries, 11,330 adults underwent randomization; 2750 were assigned to receive remdesivir, 954 to hydroxychloroquine, 1411 to lopinavir (without interferon), 2063 to interferon (including 651 to interferon plus lopinavir), and 4088 to no trial drug.\nAdherence was 94 to 96% midway through treatment, with 2 to 6% crossover.\nIn total, 1253 deaths were reported (median day of death, day 8; interquartile range, 4 to 14).\nThe Kaplan-Meier 28-day mortality was 11.8% (39.0% if the patient was already receiving ventilation at randomization and 9.5% otherwise).\nDeath occurred in 301 of 2743 patients receiving remdesivir and in 303 of 2708 receiving its control (rate ratio, 0.95; 95% confidence interval [CI], 0.81 to 1.11; P\u2009=\u20090.50), in 104 of 947 patients receiving hydroxychloroquine and in 84 of 906 receiving its control (rate ratio, 1.19; 95% CI, 0.89 to 1.59; P\u2009=\u20090.23), in 148 of 1399 patients receiving lopinavir and in 146 of 1372 receiving its control (rate ratio, 1.00; 95% CI, 0.79 to 1.25; P\u2009=\u20090.97), and in 243 of 2050 patients receiving interferon and in 216 of 2050 receiving its control (rate ratio, 1.16; 95% CI, 0.96 to 1.39; P\u2009=\u20090.11).\nNo drug definitely reduced mortality, overall or in any subgroup, or reduced initiation of ventilation or hospitalization duration.\nThese remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. (Funded by the World Health Organization; ISRCTN Registry number, ISRCTN83971151; ClinicalTrials.gov number, NCT04315948.).\nCopyright \u00a9 2020 Massachusetts Medical Society.\n", "Evidence Map": {"Enrollment": [{"term": "Covid-19-Interim WHO Solidarity", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 62}, {"term": "hospitalized", "negation": "affirmed", "UMLS": {}, "start": 187, "end": 199}, {"term": "coronavirus disease", "negation": "affirmed", "UMLS": {}, "start": 205, "end": 224}, {"term": "inpatients", "negation": "affirmed", "UMLS": {}, "start": 21, "end": 31}, {"term": "Covid-19", "negation": "affirmed", "UMLS": {}, "start": 37, "end": 45}, {"term": "ventilation", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 102}, {"term": "hospitalized patients", "negation": "negated", "UMLS": {}, "start": 103, "end": 124}, {"term": "Covid-19", "negation": "negated", "UMLS": {}, "start": 130, "end": 138}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results .", "Evidence Elements": {"Participant": [{"term": "Covid-19-Interim WHO Solidarity", "negation": "affirmed", "UMLS": {}, "start": 31, "end": 62}], "Intervention": [{"term": "Repurposed Antiviral Drugs", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 26, "has_chemical": [{"text": "antiviral drugs", "maps_to": "C0003451:antiviral drugs", "start": 11, "end": 26}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "BACKGROUND", "Text": "World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir , hydroxychloroquine , lopinavir , and interferon beta-1a-in patients hospitalized with coronavirus disease 2019 ( Covid-19 ) .", "Evidence Elements": {"Participant": [{"term": "hospitalized", "negation": "affirmed", "UMLS": {}, "start": 187, "end": 199}, {"term": "coronavirus disease", "negation": "affirmed", "UMLS": {}, "start": 205, "end": 224}], "Intervention": [{"term": "remdesivir", "negation": "affirmed", "UMLS": {}, "start": 106, "end": 116, "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, {"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 119, "end": 137, "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, {"term": "lopinavir", "negation": "affirmed", "UMLS": {}, "start": 140, "end": 149, "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, {"term": "interferon beta-1a-in", "negation": "affirmed", "UMLS": {}, "start": 156, "end": 177, "has_chemical": [{"text": "interferon beta", "maps_to": "C0751599:interferon beta", "start": 0, "end": 15}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "We randomly assigned inpatients with Covid-19 equally between one of the trial drug regimens that was locally available and open control ( up to five options , four active and the local standard of care ) .", "Evidence Elements": {"Participant": [{"term": "inpatients", "negation": "affirmed", "UMLS": {}, "start": 21, "end": 31}, {"term": "Covid-19", "negation": "affirmed", "UMLS": {}, "start": 37, "end": 45}], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "The intention-to-treat primary analyses examined in-hospital mortality in the four pairwise comparisons of each trial drug and its control ( drug available but patient assigned to the same care without that drug ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "control", "negation": "affirmed", "UMLS": {}, "start": 131, "end": 138, "has_relation": "N/A"}], "Outcome": [{"term": "in-hospital mortality", "negation": "affirmed", "UMLS": {}, "start": 49, "end": 70}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "METHODS", "Text": "Rate ratios for death were calculated with stratification according to age and status regarding mechanical ventilation at trial entry .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "Rate ratios for death", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 21}], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "At 405 hospitals in 30 countries , 11,330 adults underwent randomization ; 2750 were assigned to receive remdesivir , 954 to hydroxychloroquine , 1411 to lopinavir ( without interferon ) , 2063 to interferon ( including 651 to interferon plus lopinavir ) , and 4088 to no trial drug .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "remdesivir", "negation": "affirmed", "UMLS": {}, "start": 105, "end": 115, "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, {"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 125, "end": 143, "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, {"term": "lopinavir ( without interferon", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 184, "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}, {"text": "interferon", "maps_to": "C0733470:interferon", "start": 18, "end": 28, "has_negation": ["without"]}], "has_relation": "without (C0674432->C0733470)"}, {"term": "interferon", "negation": "negated", "UMLS": {}, "start": 174, "end": 184, "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}, {"term": "interferon", "negation": "negated", "UMLS": {}, "start": 174, "end": 184, "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Adherence was 94 to 96 % midway through treatment , with 2 to 6 % crossover .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "Adherence", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 9}], "Observation": [{"term": "94 to 96 %", "negation": "affirmed", "UMLS": {}, "start": 14, "end": 24}, {"term": "2", "negation": "affirmed", "UMLS": {}, "start": 57, "end": 58}], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "In total , 1253 deaths were reported ( median day of death , day 8 ; interquartile range , 4 to 14 ) .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [{"term": "deaths", "negation": "affirmed", "UMLS": {}, "start": 16, "end": 22}, {"term": "median day of death", "negation": "affirmed", "UMLS": {}, "start": 39, "end": 58}], "Observation": [], "Count": [{"term": "1253", "negation": "affirmed", "UMLS": {}, "start": 11, "end": 15}]}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "The Kaplan-Meier 28-day mortality was 11.8 % ( 39.0 % if the patient was already receiving ventilation at randomization and 9.5 % otherwise ) .", "Evidence Elements": {"Participant": [{"term": "ventilation", "negation": "affirmed", "UMLS": {}, "start": 91, "end": 102}], "Intervention": [], "Outcome": [{"term": "Kaplan-Meier 28-day mortality", "negation": "affirmed", "UMLS": {}, "start": 4, "end": 33}], "Observation": [{"term": "11.8 %", "negation": "affirmed", "UMLS": {}, "start": 38, "end": 44}, {"term": "39.0 %", "negation": "affirmed", "UMLS": {}, "start": 47, "end": 53}], "Count": []}, "Evidence Propositions": []}, {"Section": "RESULTS", "Text": "Death occurred in 301 of 2743 patients receiving remdesivir and in 303 of 2708 receiving its control ( rate ratio , 0.95 ; 95 % confidence interval [ CI ] , 0.81 to 1.11 ; P= 0.50 ) , in 104 of 947 patients receiving hydroxychloroquine and in 84 of 906 receiving its control ( rate ratio , 1.19 ; 95 % CI , 0.89 to 1.59 ; P= 0.23 ) , in 148 of 1399 patients receiving lopinavir and in 146 of 1372 receiving its control ( rate ratio , 1.00 ; 95 % CI , 0.79 to 1.25 ; P= 0.97 ) , and in 243 of 2050 patients receiving interferon and in 216 of 2050 receiving its control ( rate ratio , 1.16 ; 95 % CI , 0.96 to 1.39 ; P= 0.11 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "remdesivir", "negation": "affirmed", "UMLS": {}, "start": 49, "end": 59, "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 93, "end": 100, "has_relation": "N/A"}, {"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 217, "end": 235, "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 93, "end": 100, "has_relation": "N/A"}, {"term": "lopinavir", "negation": "affirmed", "UMLS": {}, "start": 368, "end": 377, "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, {"term": "control", "negation": "affirmed", "UMLS": {}, "start": 93, "end": 100, "has_relation": "N/A"}], "Outcome": [{"term": "Death", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 5}], "Observation": [], "Count": [{"term": "301 of 2743 patients", "negation": "affirmed", "UMLS": {}, "start": 18, "end": 38}, {"term": "303 of 2708", "negation": "affirmed", "UMLS": {}, "start": 67, "end": 78}, {"term": "104 of 947 patients", "negation": "affirmed", "UMLS": {}, "start": 187, "end": 206}, {"term": "84 of 906", "negation": "affirmed", "UMLS": {}, "start": 243, "end": 252}, {"term": "148 of 1399 patients", "negation": "affirmed", "UMLS": {}, "start": 337, "end": 357}, {"term": "146 of 1372", "negation": "affirmed", "UMLS": {}, "start": 385, "end": 396}, {"term": "243 of", "negation": "affirmed", "UMLS": {}, "start": 485, "end": 491}]}, "Evidence Propositions": [{"Intervention": {"term": "remdesivir", "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "", "Count": "301 of 2743 patients", "Outcome": "Death"}, {"Intervention": {"term": "control", "has_relation": "N/A"}, "Observation": "", "Count": "303 of 2708", "Outcome": "Death"}, {"Intervention": {"term": "hydroxychloroquine", "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, "Observation": "", "Count": "104 of 947 patients", "Outcome": "Death"}, {"Intervention": {"term": "lopinavir", "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, "Observation": "", "Count": "148 of 1399 patients", "Outcome": "Death"}, {"Intervention": {"term": "hydroxychloroquine", "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, "Observation": "", "Count": "243 of", "Outcome": "Death"}]}, {"Section": "RESULTS", "Text": "No drug definitely reduced mortality , overall or in any subgroup , or reduced initiation of ventilation or hospitalization duration .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "drug", "negation": "negated", "UMLS": {}, "start": 3, "end": 7, "has_chemical": [{"text": "drug", "maps_to": "C0013227:drug", "start": 0, "end": 4}], "has_relation": "N/A"}], "Outcome": [{"term": "mortality", "negation": "negated", "UMLS": {}, "start": 27, "end": 36}, {"term": "initiation of ventilation", "negation": "negated", "UMLS": {}, "start": 79, "end": 104}], "Observation": [{"term": "reduced", "negation": "negated", "UMLS": {}, "start": 19, "end": 26}, {"term": "reduced", "negation": "negated", "UMLS": {}, "start": 19, "end": 26}], "Count": []}, "Evidence Propositions": []}, {"Section": "CONCLUSIONS", "Text": "These remdesivir , hydroxychloroquine , lopinavir , and interferon regimens had little or no effect on hospitalized patients with Covid-19 , as indicated by overall mortality , initiation of ventilation , and duration of hospital stay . ( Funded by the World Health Organization ; ISRCTN Registry number , ISRCTN83971151 ; ClinicalTrials.gov number , NCT04315948 . ) .", "Evidence Elements": {"Participant": [{"term": "hospitalized patients", "negation": "negated", "UMLS": {}, "start": 103, "end": 124}, {"term": "Covid-19", "negation": "negated", "UMLS": {}, "start": 130, "end": 138}], "Intervention": [{"term": "remdesivir", "negation": "affirmed", "UMLS": {}, "start": 6, "end": 16, "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, {"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 19, "end": 37, "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, {"term": "lopinavir", "negation": "affirmed", "UMLS": {}, "start": 40, "end": 49, "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, {"term": "interferon regimens", "negation": "affirmed", "UMLS": {}, "start": 56, "end": 75, "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}], "Outcome": [{"term": "overall mortality", "negation": "negated", "UMLS": {}, "start": 157, "end": 174}, {"term": "initiation of ventilation", "negation": "negated", "UMLS": {}, "start": 177, "end": 202}, {"term": "duration of hospital stay", "negation": "negated", "UMLS": {}, "start": 209, "end": 234}], "Observation": [{"term": "little or no effect", "negation": "affirmed", "UMLS": {}, "start": 80, "end": 99}], "Count": []}, "Evidence Propositions": [{"Intervention": {"term": "remdesivir", "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "overall mortality", "Count": ""}, {"Intervention": {"term": "remdesivir", "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "initiation of ventilation", "Count": ""}, {"Intervention": {"term": "remdesivir", "has_chemical": [{"text": "remdesivir", "maps_to": "C4726677:remdesivir", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "duration of hospital stay", "Count": ""}, {"Intervention": {"term": "hydroxychloroquine", "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "overall mortality", "Count": ""}, {"Intervention": {"term": "hydroxychloroquine", "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "initiation of ventilation", "Count": ""}, {"Intervention": {"term": "hydroxychloroquine", "has_chemical": [{"text": "hydroxychloroquine", "maps_to": "C0020336:hydroxychloroquine", "start": 0, "end": 18}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "duration of hospital stay", "Count": ""}, {"Intervention": {"term": "lopinavir", "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "overall mortality", "Count": ""}, {"Intervention": {"term": "lopinavir", "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "initiation of ventilation", "Count": ""}, {"Intervention": {"term": "lopinavir", "has_chemical": [{"text": "lopinavir", "maps_to": "C0674432:lopinavir", "start": 0, "end": 9}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "duration of hospital stay", "Count": ""}, {"Intervention": {"term": "interferon regimens", "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "overall mortality", "Count": ""}, {"Intervention": {"term": "interferon regimens", "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "initiation of ventilation", "Count": ""}, {"Intervention": {"term": "interferon regimens", "has_chemical": [{"text": "interferon", "maps_to": "C0733470:interferon", "start": 0, "end": 10}], "has_relation": "N/A"}, "Observation": "little or no effect", "Outcome": "duration of hospital stay", "Count": ""}]}, {"Section": "UNKNOWN", "Text": "Copyright \u00a9 2020 Massachusetts Medical Society .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}